ClinicalTrials.Veeva

Menu

Effect of Educational Program About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among Newborns

D

Damanhour University

Status

Not yet enrolling

Conditions

Ventilator Associated Pneumonia

Treatments

Other: educational program about VAP

Study type

Interventional

Funder types

Other

Identifiers

NCT06066489
VAP in newborns

Details and patient eligibility

About

This study is designed to investigate the effect of educational program for nurses about preventive care bundle for prevention of ventilator associated pneumonia among newborns.

Full description

Neonatal ventilator associated pneumonia (VAP) is a common nosocomial infection and a frequent reason for empirical antibiotic therapy in NICUs. Ventilator associated pneumonia (VAP) is defined as a nosocomial lower airway infection in intubated patients with onset after 48 h or more of invasive mechanical ventilation.Prevention of VAP has been primarily achieved by the "bundle approach"; this involves the simultaneous application of several preventive strategies for all patients.In Egypt and other developing countries, reports on the success of VAP intervention strategies, particularly among neonates, are scarce. So, it is important to conduct educational programs for nurses about VAP to decrease its incidence.

Enrollment

137 estimated patients

Sex

All

Ages

3 to 30 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age ≥34 weeks
  • Intubated newborns and those expected to receive mechanical ventilation for more than 48 hours.

Exclusion criteria

  • Newborns with diagnosis of pneumonia at the time of admission.
  • Newborns developed pneumonia in the first 48 hours of mechanical ventilation.
  • Newborns subjected to reintubation.
  • Immunosuppressed newborns.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

137 participants in 2 patient groups

Nurses
Experimental group
Description:
Nurses will be assessed first about their knowledge about VAP then they will receive an educational program about VAP and will be assessed immediately and 3 months after the program
Treatment:
Other: educational program about VAP
newborns
Experimental group
Description:
the prevalence of VAP will be assessed among all ventilated newborns who will meet inclusion criteria in the study before implementing the program, immediately and 3 months after the program using PNU1
Treatment:
Other: educational program about VAP

Trial contacts and locations

0

Loading...

Central trial contact

Basma Ibrahim Khamis, Doctoral

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems